Krumpl G - Search Results

1

Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone.

El-Kasaby A, Boytsov D, Kasture A, Krumpl G, Hummel T, Freissmuth M, Sandtner W. El-Kasaby A, et al. Among authors: krumpl g. Mol Pharmacol. 2024 Jun 18;106(1):56-70. doi: 10.1124/molpharm.124.000881. Mol Pharmacol. 2024. PMID: 38769018

2

Answering letter to remark of Dr's Frank and Fitzgerald.

Krumpl G. Krumpl G. Eur J Clin Pharmacol. 2018 May;74(5):673-674. doi: 10.1007/s00228-017-2409-x. Epub 2018 Jan 10. Eur J Clin Pharmacol. 2018. PMID: 29322330 No abstract available.

3

Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.

Krumpl G, Ulč I, Trebs M, Kadlecová P, Hodisch J, Husch B. Krumpl G, et al. Clin Pharmacol Drug Dev. 2022 Mar;11(3):309-317. doi: 10.1002/cpdd.1025. Epub 2021 Oct 16. Clin Pharmacol Drug Dev. 2022. PMID: 34655181 Clinical Trial.

4

Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.

Krumpl G, Winkler M, Schneider W, Raberger G. Krumpl G, et al. Br J Pharmacol. 1988 May;94(1):55-64. doi: 10.1111/j.1476-5381.1988.tb11499.x. Br J Pharmacol. 1988. PMID: 3401644 Free PMC article.

5

Pharmacodynamic and -kinetic Behavior of Low-, Intermediate-, and High-Dose Landiolol During Long-Term Infusion in Whites.

Krumpl G, Ulč I, Trebs M, Kadlecová P, Hodisch J, Maurer G, Husch B. Krumpl G, et al. J Cardiovasc Pharmacol. 2017 Jul;70(1):42-51. doi: 10.1097/FJC.0000000000000495. J Cardiovasc Pharmacol. 2017. PMID: 28437278 Clinical Trial.

6

Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.

Krumpl G, Ulč I, Trebs M, Kadlecová P, Hodisch J, Maurer G, Husch B. Krumpl G, et al. J Cardiovasc Pharmacol. 2018 Mar;71(3):137-146. doi: 10.1097/FJC.0000000000000554. J Cardiovasc Pharmacol. 2018. PMID: 29112591 Clinical Trial.

7

Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.

Krumpl G, Ulc I, Trebs M, Kadlecová P, Hodisch J. Krumpl G, et al. Eur J Clin Pharmacol. 2017 Apr;73(4):417-428. doi: 10.1007/s00228-016-2176-0. Epub 2017 Jan 13. Eur J Clin Pharmacol. 2017. PMID: 28091703 Clinical Trial.

8

Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation.

Krumpl G, Todt H, Krejcy K, Raberger G. Krumpl G, et al. Br J Pharmacol. 1990 Aug;100(4):855-61. doi: 10.1111/j.1476-5381.1990.tb14104.x. Br J Pharmacol. 1990. PMID: 2207504 Free PMC article.

9

Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults.

Krumpl G, Ulč I, Trebs M, Kadlecová P, Hodisch J. Krumpl G, et al. BMC Pharmacol Toxicol. 2020 Nov 25;21(1):82. doi: 10.1186/s40360-020-00462-x. BMC Pharmacol Toxicol. 2020. PMID: 33239108 Free PMC article. Clinical Trial.

10

Effects of beta-adrenoceptor antagonism upon delayed reperfusion arrhythmias in conscious dogs.

Todt H, Krumpl G, Krejcy K, Raberger G. Todt H, et al. Among authors: krumpl g. Eur J Pharmacol. 1991 Apr 17;196(2):109-15. doi: 10.1016/0014-2999(91)90415-m. Eur J Pharmacol. 1991. PMID: 1678714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters